Clinical Trials Logo

Chronic Cutaneous Ulcer clinical trials

View clinical trials related to Chronic Cutaneous Ulcer.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT04058197 Withdrawn - Sickle Cell Disease Clinical Trials

Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment

D-SCOUT
Start date: July 21, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Approximately 60 subjects will be enrolled into this double-blind, placebo-controlled study for the Deferoxamine Intradermal Delivery Patch (DIDP). Those subjects who pass Screening will enter into the 2-week Standard of Care (SOC) Run-In period. During this time, ulcers will be assessed to check healing based on digital planimetry, and qualitative features of the ulcer. Subjects who meet eligibility criteria at the end of the 2-week Run-in Period will be randomized into active and control groups (2 active to 1 placebo) and enter the 12-week Treatment Period. At each visit during the Treatment Period, the target ulcer will be measured by digital photographic planimetry, the Principal Investigator will assess the wound qualitative attributes, and the DIDP (or placebo patch) will be placed as the primary wound dressing. At each visit the subject will also receive/review a daily diary to document pain , study drug compliance, and analgesic use.